Literature DB >> 32621213

Characterization of troponin I levels post synchronized direct current cardioversion of atrial arrhythmias in patients with and without cardiomyopathy.

Ryan T Sless1, Gerry Allen2, Nathaniel E Hayward3, Gerry Fahy2.   

Abstract

BACKGROUND: Cardiac-specific markers of myocardial injury, such as troponin I (TnI), are often elevated following procedures that stimulate the myocardium. This study aimed to determine the effect of synchronized direct current (DC) cardioversion of atrial arrhythmias on myocardial injury 6-h post-procedure, as measured by cardiac TnI in patients with and without cardiomyopathy.
METHODS: Seventy-three individuals (59 M:14 F) participated in this study. Inclusion criteria were subjects 18 and older undergoing DC cardioversion for an atrial arrhythmia, including elective and non-elective admissions. Exclusion criteria included MI or CABG within the past month, cardioversion for a ventricular arrhythmia, or recent shock by implantable internal cardioverter defibrillator. Patients underwent standard DC cardioversion procedure with blood work (TnI and CRP) prior to and 6-h post-cardioversion. Primary outcome was change in TnI. Secondary outcomes included changes in CRP, correlation of TnI with cumulative energy and LVM, and a sub-group analysis in patients with cardiomyopathy.
RESULTS: There was no significant change in TnI following cardioversion (20.4 ± 7.9 vs. 17.5 ± 6.5 ng/L, F(1,72) = 2.651, p = 0.108). When stratified by cardiomyopathy status, there was a statistically significant reduction in TnI following cardioversion in the non-cardiomyopathy group (6.7 ± 3.7 ng/L vs. 6.2 ± 3.2 ng/L, F(1,58) = 6.481, p = 0.014) and a clinically significant reduction in the cardiomyopathy group (74.4 ± 136.7 ng/L vs. 54.6 ± 104.3 ng/L, F(1,13) = 3.676, p = 0.07). There was no significant relationship between change in TnI and cumulative energy or LVM (r = 0.137, p = 0.306 and r = 0.125, p = 0.412 respectively).
CONCLUSIONS: Synchronized DC cardioversion of an atrial arrhythmia did not cause myocardial injury 6-h post-cardioversion. Sub-group analysis suggests that cardioversion of patients with cardiomyopathy may result in normalization of TnI levels.

Entities:  

Keywords:  Atrial arrhythmias; Cardiomyopathy; Cardioversion; Electrophysiology; Troponin

Year:  2020        PMID: 32621213     DOI: 10.1007/s10840-020-00814-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  22 in total

1.  C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Authors:  M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

Review 2.  The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe.

Authors:  Gregory Y H Lip; Carolyn M Brechin; Deirdre A Lane
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

3.  Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation.

Authors:  Dariusz Artur Kosior; Grzegorz Opolski; Wiesław Tadeusiak; Tomasz Chwyczko; Beata Wozakowska-Kaplon; Sławomir Stawicki; Krzysztof J Filipak; Daniel Rabczenko
Journal:  Pacing Clin Electrophysiol       Date:  2005-01       Impact factor: 1.976

4.  Atrial fibrillation and plasma troponin I elevation after cardiac surgery: relation to inflammation-associated parameters.

Authors:  Boris Knayzer; Dan Abramov; Bilenko Natalia; David Tovbin; Amir Ganiel; Amos Katz
Journal:  J Card Surg       Date:  2007 Mar-Apr       Impact factor: 1.620

5.  Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.

Authors:  Luigi Oltrona; Filippo Ottani; Marcello Galvani
Journal:  Am Heart J       Date:  2004-09       Impact factor: 4.749

6.  Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value.

Authors:  Ertan Okmen; Nese Cam; Arda Sanli; Sennur Unal; Zeynep Tartan; Mutlu Vural
Journal:  Angiology       Date:  2006 Mar-Apr       Impact factor: 3.619

7.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

8.  High Sensitivity Cardiac Troponin T Levels after Elective Cardioversion for Atrial Fibrillation/Flutter.

Authors:  Zaza Iakobishvili; Adaya Weissler; Kiril Buturlin; Gustavo Goldenberg; Boris Strassberg; Ruth Tur; David Hasdai
Journal:  Isr Med Assoc J       Date:  2015-10       Impact factor: 0.892

9.  Troponin testing after cardiac surgery.

Authors:  J L Januzzi
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2009

10.  Evidence for Acute Myocardial and Skeletal Muscle Injury after Serial Transthoracic Shocks in Healthy Swine.

Authors:  Dominik P Guensch; Janelle Yu; Gobinath Nadeshalingam; Kady Fischer; Jane Shearer; Matthias G Friedrich
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.